New Treatment Option for Kidney Transplant Recipients Monthly Prescribing Reference Astagraf XL (tacrolimus extended-release capsules; Astellas) has been approved for the prophylaxis of organ rejection in patients receiving a kidney transplant with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction. |
